Literature DB >> 10685071

Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?

H A Lehr1, F Bittinger, C J Kirkpatrick.   

Abstract

Sepsis is a frequent complication of multiple organ dysfunction syndrome and remains a major problem of intensive care medicine. It is also a common factor in the final cause of death in hospital populations. Clinical observations, assisted by invasive monitoring techniques as well as pathological-anatomical studies, clearly indicate that microcirculatory dysfunction lies at the centre of sepsis pathogenesis. Numerous animal models, from rodents to primates, many of which employ bacteria or their toxins, especially endotoxins, have helped to shed light on the pathomechanisms leading to this dysregulation in the peripheral circulation. Among these are activation of humoral and cellular inflammatory mediator systems, with special emphasis on neutrophil-endothelial interactions, affecting endothelial barrier function and vasoregulation and ultimately leading to severely perturbed oxygen transport and utilization. In vitro studies have provided more insight into the molecular mechanisms involved in this microcirculatory dysfunction, although much more attention must be directed towards microvascular endothelial cells and the role of heterogeneity of response in various vascular beds. These experimental data must in turn be validated by comparing with the human in situ situation, both clinical and morphological. This review aims at a critical appraisal of the clinical and experimental evidence for sepsis-induced dysregulation of the microcirculation and how knowledge of the underlying cellular and molecular pathology could be used to make therapy more rational and effective. To date, therapeutic approaches, such as anti-cytokine and anti-oxidant regimens, which have been highly successful in experimental models, have failed to demonstrate clinical efficacy. Newer approaches, such as targeting the coagulation system, nitric oxide synthesis or intracellular signal transduction, are also discussed. The necessity to focus on the role of anti-inflammatory mediators, as well as the pathogenetic significance of important molecular groups, such as the heat shock proteins, which until now have been given scant attention, will be stressed. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685071     DOI: 10.1002/(SICI)1096-9896(200002)190:3<373::AID-PATH593>3.0.CO;2-3

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  32 in total

1.  Incidence and impact of skin mottling over the knee and its duration on outcome in critically ill patients.

Authors:  Rémi Coudroy; Angéline Jamet; Jean-Pierre Frat; Anne Veinstein; Delphine Chatellier; Véronique Goudet; Severin Cabasson; Arnaud W Thille; René Robert
Journal:  Intensive Care Med       Date:  2014-12-17       Impact factor: 17.440

2.  STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.

Authors:  C J Godshall; A B Lentsch; J C Peyton; M J Scott; W G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Protective effect of ginsenosides Rg1 and Re on lipopolysaccharide-induced sepsis by competitive binding to Toll-like receptor 4.

Authors:  Fei Su; Yin Xue; Yuemin Wang; Lili Zhang; Wangxue Chen; Songhua Hu
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

Review 4.  [Microcirculatory monitoring of sepsis].

Authors:  A Bauer; D Bruegger; F Christ
Journal:  Anaesthesist       Date:  2005-12       Impact factor: 1.041

Review 5.  Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.

Authors:  M P Kim; S I Park; S Kopetz; G E Gallick
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

6.  Cerebral microcirculation is impaired during sepsis: an experimental study.

Authors:  Fabio Silvio Taccone; Fuhong Su; Charalampos Pierrakos; Xinrong He; Syril James; Olivier Dewitte; Jean-Louis Vincent; Daniel De Backer
Journal:  Crit Care       Date:  2010-07-28       Impact factor: 9.097

Review 7.  [Microcirculation of intensive care patients. From the physiology to the bedside].

Authors:  H Knotzer; W Hasibeder
Journal:  Anaesthesist       Date:  2008-02       Impact factor: 1.041

Review 8.  The microcirculation as a diagnostic and therapeutic target in sepsis.

Authors:  Andrea Nencioni; Stephen Trzeciak; Nathan I Shapiro
Journal:  Intern Emerg Med       Date:  2009-08-26       Impact factor: 3.397

9.  Role of cardiac- and myeloid-MyD88 signaling in endotoxin shock: a study with tissue-specific deletion models.

Authors:  Yan Feng; Lin Zou; Chan Chen; Dan Li; Wei Chao
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892

10.  FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide.

Authors:  Douglas D Bannerman; Kristine T Eiting; Robert K Winn; John M Harlan
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.